Neurology Advisor: No clear benefit for anticoagulants over antiplatelets in stroke patients with cancer

| Posted in Brain Education, Brain Injury, Brain Research

Findings from a small preliminary clinical trial (TEACH; ClinicalTrials.gov identifier: NCT01763606) of 10 patients with cancer and acute ischemic stroke (AIS) suggest that there is no significant benefit for anticoagulation vs antiplatelet therapy on cumulative rates of major bleeding, thromboembolic events, and survival. The results were published in JAMA Neurology. (February 7, 2018)

Read the full article here